Abstract:OBJECTIVE:To investigate the therapeutic effects of pulmonary surfactant (PS) on smoking-induced lung injury in rats.METHODS:Thirty male Wistar rats were randomly divided into four groups: normal control group (n = 8, killed by the end of the 7th week), 3-week smoking group (n = 8, in haling mainstream smoke of cigarette for 3 weeks and killed by the end of the 3rd week), 7-week smoking group (n = 8, in haling mainstream smoke of cigarette for 7 weeks and killed by the end of the 7th week), and PS treatment group (n = 6, inhaling mainstream smoke of cigarette for 7 weeks and given PS 25 mg/kg via trachea per week for 4 weeks since the end of the 3rd week of smoking, totally 5 times, and then killed by the end of the 7th week). The histological changes of respiratory bronchioles were observed by light microscopy and transmission electron microscopy. The airway resistance in expiratory phase was tested by pulmonary function test apparatus. The expression of Clara cell 16KD protein (CC16) mRNA and SP-C mRNA in lung tissue was determined by RT-PCR and the expression of CC16 protein in bronchiole epithelial cells was determined by immunohistochemistry.RESULTS:The proportion of Clara cell to the respiratory bronchiole epithelial cells was 62% in the normal controls, 40% in the 3-week smoking group, 33% in the 7-week smoking group, and 56% in the PS treatment group (significantly lower in comparison with that in the 7-week group, P < 0.05). Degeneration of Clara cells, hyperplasis of type II pneumocytes and increase of area of smooth muscle in bronchioles were observed in the three smoking groups, however, such changes were the most distinct in the 7-week smoking group and the less distinct in the PS treatment group (P < 0.05). In comparison with those in the normal control group, the expression of CC16 mRNA, SP-C mRNA and CC16 protein were lower in the three smoking groups. However, the expressions of CC16 mRNA and the expression of SP-C mRNA in the PS treatment group were significantly higher than those in the 7-week smoking group (11.8 +/- 5.1 vs 3.0 +/- 0.9, and 8.5 +/- 3.4 vs 2.5 +/- 0.9, both P < 0.05). The mean area of smooth muscle in bronchioles with the diameter less than 200 micro m was significantly larger than that in the control group, however, the mean area in the PS treatment group was significantly less than that in the 7-week smoking group (P < 0.05). The airway resistance in the control group (1.62 +/- 0.08 cmH(2)O. L(-1). s(-1)) was lower than those in the 3 smoking groups, however, the airway resistance in the PS treatment group was significantly lower than that in the 7-week group (1.70 +/- 0.07 cmH(2)O. L(-1). s(-1) vs 2.98 +/- 0.65 cmH(2)O. L(-1). s(-1), P < 0.05).CONCLUSION:PS is effective in alleviating smoking-induced lung injury in rats. One of the mechanisms might be attenuation of the damage in Clara cells and type II pneumocytes due to cigarette smoking.

[Alterations of Pulmonary Surfactant During Pseudomonas Aeruginosa Pneumonia of Immunocompromised Rats].

Inflammatory Reaction and Alterations of Pulmonary Surfactant in Pseudomonas Aeruginosa Pneumonia in Immunocompromised Rats.

Alteration of Surfactant Proteins A and D in Bronchoalveolar Lavage Fluid of Pneumocystis Carinii Pneumonia

Expression of IFN-γ and IL-4 in Pulmonary Infection with Pseudomonas Aeruginosa in Immunocompromised Rats

[Protective Effects and Mechanisms of Recombinant Human Superoxide Dismutase in Acute Lung Injury of Rats Following Meconium Aspiration].

Keratinocyte Growth Factor and Surfactant Protein A in Pseudomonas Aeruginosa Pneumonia: Changes and Significances

The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats

Changes in Pulmonary Surfactant after Acute Lung Injury Induced by Oleic Acid

Protective effects of pseudomonas aeruginosa mannose-sensitive hemagglutinin on acute lung injury in septic rats

Increased Claudin-3, -4 and -18 Levels in Bronchoalveolar Lavage Fluid Reflect Severity of Acute Lung Injury.

Dynamic alterations in the lung microbiota in a rat model of lipopolysaccharide-induced acute lung injury

[Study of Rat Beta-Defensin-2 Gene and Protein Expression in Ventilator-Associated Pneumonia].

Effects of Pseudomonas aeruginosa-mannose-sensitive hem agglutinin on the inflammatory re-sponse in lung tissues ofseptic rats

Loss of Surfactant Protein A Alters Perinatal Lung Morphology and Susceptibility to Hyperoxia-Induced Bronchopulmonary Dysplasia

The Changes of Four Cell-Resource Biomarkers in Rats with Acute Respiratory Distress Syndrome

Phospholipid Changes of Pulmonary Surfactant in Rats with Pulmonary Edema after Seawater Drowning

Effect of recruitment maneuver on pulmonary surfactant in young piglets with acute lung injury

[Intra-amniotic administration of pulmonary surfactant improves lung ultrastructural pathology and enhances surfactant protein A expression in fetal rabbits with intrauterine infection]

Attenuated Mrna Expression of Inflammatory Mediators in Neonatal Rat Lung Following Lipopolysaccharide Treatment

Therapeutic Effects of Pulmonary Surfactant on Smoking-Induced Lung Injury in Rats, an Experimental Study

Study of Acute Lung Injury after Intestinal Ischemia-Reperfusion in Rats